Defensin vs Magainin — mechanism, half-life, dosing, and research status compared. Which is right for your protocol?
Defensins are a superfamily of small, cysteine-rich cationic antimicrobial peptides that form a critical component of innate immunity across virtually all multicellular organisms. In humans, alpha-defensins (HNP-1 to -4 in neutrophils; HD-5, HD-6 in intestinal Paneth cells) and b...
Calculate Defensin dose →Magainins are cationic, alpha-helical antimicrobial peptides (AMPs) isolated from the skin of the African clawed frog Xenopus laevis by Michael Zasloff in 1987. They are among the founding members of the frog skin AMP family and established the concept of innate immune peptide de...
Calculate Magainin dose →| Parameter | Defensin | Magainin |
|---|---|---|
| Category | Antimicrobial Peptide | Antimicrobial Peptide |
| Research | Research/Therapeutic Development | Clinical (topical) |
| Half-Life | Minutes-hours (tissue dependent) | Minutes (plasma); hours (topical) |
| Typical Dose | Research only | Pexiganan cream 0.8% |
| Frequency | N/A | Twice daily (topical) |
| Route | Endogenous; topical/intranasal (research) | Topical (clinical), IV (research) |
| FDA Status | No approval (research stage) | Under review (pexiganan) |
Use ASCEND's free reconstitution calculator to get exact syringe draw amounts for your vial.
For research use only. Not medical advice. ASCEND does not conduct or endorse any specific research protocol. Always consult relevant scientific literature and regulatory guidelines.